Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Recruiting2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06902896Phase 1/2Recruiting
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
Dilated Cardiomyopathy (DCM)Heart Failure
PrincipalinvestigatorStart date: 2025-04-22
NCT06548204Phase 2Recruiting
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
ST-segment Elevation Myocardial Infarction (STEMI)
PrincipalinvestigatorStart date: 2025-01-20
NCT05887830Phase 1/2Unknown
Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial
Acute Anterior ST Segment Elevation Myocardial Infarction
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06902896Phase 1/2PrincipalInvestigator

Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM)Heart Failure
Recruiting
NCT06548204Phase 2PrincipalInvestigator

Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial

ST-segment Elevation Myocardial Infarction (STEMI)
Recruiting
NCT05887830Phase 1/2PrincipalInvestigator

Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial

Acute Anterior ST Segment Elevation Myocardial Infarction
Unknown

All 3 trials loaded